Kailera Therapeutics, Inc. · NASDAQ:KLRA

Kaplan Andrew T. bought 8,398,438 Kailera Therapeutics, Inc. shares (Form 4)

Traded Apr 20, 2026 · Filed Apr 20, 2026

On Apr 20, 2026, Kaplan Andrew T. (Director, 10% owner) bought 8,398,438 Kailera Therapeutics, Inc. shares at US$16.00 for US$134M, leaving 26,255,581 shares. Filed Apr 20, 2026 (Form 4).

Bought
8,398,438 shares
Price
US$16.00
Value
US$134M
Holding after
26,255,581 shares (held indirectly)
Trading plan
No
Role
Director, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 20, 2026Common StockConversion17,857,14317,857,143Indirect
Apr 20, 2026Common StockBuy8,398,438US$16.0026,255,581Indirect

Source

View original at SEC

Related